Law Firms Urge Nektar Investors to Join Securities Suit Before May 5

Overview

• DJS Law Group and The Schall Law Firm reminded Nektar shareholders of a May 5, 2026 deadline to seek lead‑plaintiff status in a filed securities class action.
• The complaint alleges Nektar enrolled patients in the REZOLVE‑AA study of rezpegaldesleukin in ways that did not follow the trial protocol.
• The firms say those enrollment issues likely hurt the study’s results and made company statements during February 26 to December 15, 2025 materially misleading.
• The suit cites Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b‑5 and claims investors lost money when the market learned of the alleged problems.
• The class has not been certified and the firms note investors are not yet represented by counsel and can share in any recovery without serving as lead plaintiff.